Revolution Medicines, Inc.
RVMDW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $93.0M in total; no superinvestor holds it.
Other share classesRVMD
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Revolution Medicines, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 17 filings
- 9 insiders, $76.7M in total
- Insiders trading
- 9
- Net value
- −$76.7M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Revolution Medicines, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Cislini Jeff | SVP & General Counsel | 51,776 | Sep 29, 2026 | 10 |
| Mancini Anthony | See Remarks | 39,765 | Sep 28, 2026 | 8 |
| Anderson Elizabeth M | Director | 4,333 | Sep 24, 2026 | 3 |
| Sandler Alan B. | Chief Development Officer | 52,868 | Sep 18, 2026 | 1 |
| Kelsey Stephen Michael | See Remarks | 286,307 | Sep 18, 2026 | 7 |
| Horn Margaret A | Chief Operating Officer | 149,680 | Sep 18, 2026 | 7 |
| Goldsmith Mark A | See Remarks | 253,342 | Sep 18, 2026 | 13 |
| Anders Jack | Chief Financial Officer | 119,216 | Sep 18, 2026 | 9 |
| Kim Lorence H. | Director | 0Indirect | Sep 10, 2026 | 3 |
| Patel Sushil | Director | 21,656 | Jul 1, 2026 | 2 |
| Borisy Alexis | Director | 2,340,075 | Jun 23, 2026 | 1 |
| Horning Sandra | Director | 97,765 | Jun 23, 2026 | 1 |
| Clyburn Frank | Director | 10,929 | Jun 23, 2026 | 1 |
| Borellini Flavia | Director | 26,215 | Jun 23, 2026 | 1 |
| Wang Xiaolin | See Remarks | 116,063 | Mar 19, 2026 | 2 |
| Wei Lin | Chief Medical Officer | 101,366 | Mar 19, 2026 | 2 |
| Schroeder Thilo | Director | 760,869Indirect | Dec 9, 2024 | 0 |
| Weber Barbara | Director | 13,065 | Oct 10, 2024 | 0 |
| Schmidt Eric Thomas | Director | 21,251 | Jun 12, 2023 | 0 |
| Exter Neil | Director | 28,815 | Jun 17, 2022 | 0 |
| Tepper Robert I | 10% Owner | 5,104,130 | Jun 10, 2022 | 0 |
| Third Rock Ventures III, L.P. | 10% Owner | 5,104,130 | Jun 10, 2022 | 0 |
| TRV GP III, LLC | 10% Owner | 5,104,130 | Jun 10, 2022 | 0 |
| Third Rock Ventures GP III, L.P. | 10% Owner | 5,104,130 | Jun 10, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 (view filing) | Feb 18, 2020-Mar 4, 2022 | 745 daysLate | Schroeder ThiloDirector | PPurchase | +1.09M | $26.30 | +$28.6M | New position238.2K after | 7 lots |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Anders JackSee Remarks | SSale | −170 | $24.41 | −$4.15K | −2.0%8.43K after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Wang XiaolinSee Remarks | SSale | −257 | $24.41 | −$6.27K | −2.1%11.9K after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Kelsey Stephen MichaelSee Remarks | SSale | −343 | $24.41 | −$8.37K | −0.1%251.8K after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Horn Margaret ASee Remarks | SSale | −491 | $24.41 | −$12.0K | −1.9%25.5K after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Goldsmith Mark ASee Remarks | SSale | −1.57K | $24.41 | −$38.3K | −1.9%82.6K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Anders JackSee Remarks | SSale | −166 | $30.02 | −$4.98K | −2.0%8.19K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Kelsey Stephen MichaelSee Remarks | SSale | −335 | $30.02 | −$10.1K | −0.1%252.2K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Wang XiaolinSee Remarks | SSale | −250 | $30.02 | −$7.50K | −2.0%12.2K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Goldsmith Mark ASee Remarks | SSale | −1.53K | $30.02 | −$46.0K | −3.2%46.5K after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Horn Margaret ASee Remarks | SSale | −479 | $30.02 | −$14.4K | −1.8%26.0K after |